Gardiquimod™ is an imidazoquinoline compound developed and manufactured by InvivoGen. Similarly to Imiquimod, Gardiquimod™ induces the activation of NF-κB in HEK293 cells expressing human or mouse TLR7. Interestingly, Gardiquimod™ is more potent than Imiquimod. Gardiquimod™ is specific for TLR7 when used at less than 1 µg/ml.


Specificity: human/mouse TLR7 agonist

Working concentration: 0.1 - 3 µg/ml

CAS number: 1020412-43-4

Endotoxin level: EndoFit™ (<0.001 EU/μg)

Solubility: 1 mg/ml in water


• Gardiquimod™ is available in two quantities:
- 500 μg Gardiquimod™: tlrl-gdqs
- 5 mg Gardiquimod™: tlrl-gdq-5

• sterile endotoxin-free water, 1.5 ml with #tlrl-gdqs and 10 ml with #tlrl-gdq-5.

Gardiquimod™ is provided lyophilized and shipped at room temperature. Store at -20°C. Lyophilized product is stable for 1 year at -20°C when properly stored. Upon resuspension, prepare ailquots of Gardiquimod™ and store at -20°C for long term storage. Resuspended product is stable for 6 months at -20°C. Avoid repeated freeze-thaw cycles.



Description Imidazoquinoline compound
Cat. Codetlrl-gdqs
Unit Size500 µg
Price For price or distributor address,
please select your country


Description Imidazoquinoline compound
Cat. Codetlrl-gdq-5
Unit Size5 mg
Price For price or distributor address,
please select your country
Disclaimer: Our products are provided for research purpose only. Commercial applications may require licensing from third parties.
Note that the sequence of available ORFs provided by InvivoGen can differ from a given reference Genbank record due to genetic variations and/or alternative splicing. Customers should verify that the version of a gene sold by InvivoGen is suitable for the customer needs.
Copyrights © 2011-2016 InvivoGen. All Rights Reserved. Reproduction of any materials from this site is strictly forbidden without permission for commercial use. Nonprofit use for non-commercial research and educational purposes is permitted, citation should include the URL "".